Cargando…

In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19

COVID-19 is one of the members of the coronavirus family that can easily assail humans. As of now, 10 million people are infected and above two million people have died from COVID-19 globally. Over the past year, several researchers have made essential advances in discovering potential drugs. Up to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sankar, Muthumanickam, Ramachandran, Balajee, Pandi, Boomi, Mutharasappan, Nachiappan, Ramasamy, Vidhyavathi, Prabu, Poorani Gurumallesh, Shanmugaraj, Gowrishankar, Wang, Yao, Muniyandai, Brintha, Rathinasamy, Subaskumar, Chandrasekaran, Balakumar, Bayan, Mohammad F., Jeyaraman, Jeyakanthan, Halliah, Gurumallesh Prabu, Ebenezer, Solomon King
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288047/
https://www.ncbi.nlm.nih.gov/pubmed/34291081
http://dx.doi.org/10.3389/fmolb.2021.637122
_version_ 1783724023920721920
author Sankar, Muthumanickam
Ramachandran, Balajee
Pandi, Boomi
Mutharasappan, Nachiappan
Ramasamy, Vidhyavathi
Prabu, Poorani Gurumallesh
Shanmugaraj, Gowrishankar
Wang, Yao
Muniyandai, Brintha
Rathinasamy, Subaskumar
Chandrasekaran, Balakumar
Bayan, Mohammad F.
Jeyaraman, Jeyakanthan
Halliah, Gurumallesh Prabu
Ebenezer, Solomon King
author_facet Sankar, Muthumanickam
Ramachandran, Balajee
Pandi, Boomi
Mutharasappan, Nachiappan
Ramasamy, Vidhyavathi
Prabu, Poorani Gurumallesh
Shanmugaraj, Gowrishankar
Wang, Yao
Muniyandai, Brintha
Rathinasamy, Subaskumar
Chandrasekaran, Balakumar
Bayan, Mohammad F.
Jeyaraman, Jeyakanthan
Halliah, Gurumallesh Prabu
Ebenezer, Solomon King
author_sort Sankar, Muthumanickam
collection PubMed
description COVID-19 is one of the members of the coronavirus family that can easily assail humans. As of now, 10 million people are infected and above two million people have died from COVID-19 globally. Over the past year, several researchers have made essential advances in discovering potential drugs. Up to now, no efficient drugs are available on the market. The present study aims to identify the potent phytocompounds from different medicinal plants (Zingiber officinale, Cuminum cyminum, Piper nigrum, Curcuma longa, and Allium sativum). In total, 227 phytocompounds were identified and screened against the proteins S-ACE2 and M(pro) through structure-based virtual screening approaches. Based on the binding affinity score, 30 active phytocompounds were selected. Amongst, the binding affinity for beta-sitosterol and beta-elemene against S-ACE2 showed −12.0 and −10.9 kcal/mol, respectively. Meanwhile, the binding affinity for beta-sitosterol and beta-chlorogenin against M(pro) was found to be −9.7 and −8.4 kcal/mol, respectively. Further, the selected compounds proceeded with molecular dynamics simulation, prime MM-GBSA analysis, and ADME/T property checks to understand the stability, interaction, conformational changes, binding free energy, and pharmaceutical relevant parameters. Moreover, the hotspot residues such as Lys31 and Lys353 for S-ACE2 and catalytic dyad His41 and Cys145 for M(pro) were actively involved in the inhibition of viral entry. From the in silico analyses, we anticipate that this work could be valuable to ongoing novel drug discovery with potential treatment for COVID-19.
format Online
Article
Text
id pubmed-8288047
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82880472021-07-20 In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19 Sankar, Muthumanickam Ramachandran, Balajee Pandi, Boomi Mutharasappan, Nachiappan Ramasamy, Vidhyavathi Prabu, Poorani Gurumallesh Shanmugaraj, Gowrishankar Wang, Yao Muniyandai, Brintha Rathinasamy, Subaskumar Chandrasekaran, Balakumar Bayan, Mohammad F. Jeyaraman, Jeyakanthan Halliah, Gurumallesh Prabu Ebenezer, Solomon King Front Mol Biosci Molecular Biosciences COVID-19 is one of the members of the coronavirus family that can easily assail humans. As of now, 10 million people are infected and above two million people have died from COVID-19 globally. Over the past year, several researchers have made essential advances in discovering potential drugs. Up to now, no efficient drugs are available on the market. The present study aims to identify the potent phytocompounds from different medicinal plants (Zingiber officinale, Cuminum cyminum, Piper nigrum, Curcuma longa, and Allium sativum). In total, 227 phytocompounds were identified and screened against the proteins S-ACE2 and M(pro) through structure-based virtual screening approaches. Based on the binding affinity score, 30 active phytocompounds were selected. Amongst, the binding affinity for beta-sitosterol and beta-elemene against S-ACE2 showed −12.0 and −10.9 kcal/mol, respectively. Meanwhile, the binding affinity for beta-sitosterol and beta-chlorogenin against M(pro) was found to be −9.7 and −8.4 kcal/mol, respectively. Further, the selected compounds proceeded with molecular dynamics simulation, prime MM-GBSA analysis, and ADME/T property checks to understand the stability, interaction, conformational changes, binding free energy, and pharmaceutical relevant parameters. Moreover, the hotspot residues such as Lys31 and Lys353 for S-ACE2 and catalytic dyad His41 and Cys145 for M(pro) were actively involved in the inhibition of viral entry. From the in silico analyses, we anticipate that this work could be valuable to ongoing novel drug discovery with potential treatment for COVID-19. Frontiers Media S.A. 2021-07-05 /pmc/articles/PMC8288047/ /pubmed/34291081 http://dx.doi.org/10.3389/fmolb.2021.637122 Text en Copyright © 2021 Sankar, Ramachandran, Pandi, Mutharasappan, Ramasamy, Prabu, Shanmugaraj, Wang, Muniyandai, Rathinasamy, Chandrasekaran, Bayan, Jeyaraman, Halliah and Ebenezer. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Sankar, Muthumanickam
Ramachandran, Balajee
Pandi, Boomi
Mutharasappan, Nachiappan
Ramasamy, Vidhyavathi
Prabu, Poorani Gurumallesh
Shanmugaraj, Gowrishankar
Wang, Yao
Muniyandai, Brintha
Rathinasamy, Subaskumar
Chandrasekaran, Balakumar
Bayan, Mohammad F.
Jeyaraman, Jeyakanthan
Halliah, Gurumallesh Prabu
Ebenezer, Solomon King
In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19
title In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19
title_full In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19
title_fullStr In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19
title_full_unstemmed In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19
title_short In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19
title_sort in silico screening of natural phytocompounds towards identification of potential lead compounds to treat covid-19
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288047/
https://www.ncbi.nlm.nih.gov/pubmed/34291081
http://dx.doi.org/10.3389/fmolb.2021.637122
work_keys_str_mv AT sankarmuthumanickam insilicoscreeningofnaturalphytocompoundstowardsidentificationofpotentialleadcompoundstotreatcovid19
AT ramachandranbalajee insilicoscreeningofnaturalphytocompoundstowardsidentificationofpotentialleadcompoundstotreatcovid19
AT pandiboomi insilicoscreeningofnaturalphytocompoundstowardsidentificationofpotentialleadcompoundstotreatcovid19
AT mutharasappannachiappan insilicoscreeningofnaturalphytocompoundstowardsidentificationofpotentialleadcompoundstotreatcovid19
AT ramasamyvidhyavathi insilicoscreeningofnaturalphytocompoundstowardsidentificationofpotentialleadcompoundstotreatcovid19
AT prabupooranigurumallesh insilicoscreeningofnaturalphytocompoundstowardsidentificationofpotentialleadcompoundstotreatcovid19
AT shanmugarajgowrishankar insilicoscreeningofnaturalphytocompoundstowardsidentificationofpotentialleadcompoundstotreatcovid19
AT wangyao insilicoscreeningofnaturalphytocompoundstowardsidentificationofpotentialleadcompoundstotreatcovid19
AT muniyandaibrintha insilicoscreeningofnaturalphytocompoundstowardsidentificationofpotentialleadcompoundstotreatcovid19
AT rathinasamysubaskumar insilicoscreeningofnaturalphytocompoundstowardsidentificationofpotentialleadcompoundstotreatcovid19
AT chandrasekaranbalakumar insilicoscreeningofnaturalphytocompoundstowardsidentificationofpotentialleadcompoundstotreatcovid19
AT bayanmohammadf insilicoscreeningofnaturalphytocompoundstowardsidentificationofpotentialleadcompoundstotreatcovid19
AT jeyaramanjeyakanthan insilicoscreeningofnaturalphytocompoundstowardsidentificationofpotentialleadcompoundstotreatcovid19
AT halliahgurumalleshprabu insilicoscreeningofnaturalphytocompoundstowardsidentificationofpotentialleadcompoundstotreatcovid19
AT ebenezersolomonking insilicoscreeningofnaturalphytocompoundstowardsidentificationofpotentialleadcompoundstotreatcovid19